M&A

M&A

Laurus Labs hikes stake in Laurus Bio to 88%

Business Standard  

Hyderabad-headquartered, publicly-listed pharmaceutical company Laurus Labs has successfully completed the acquisition of Bengaluru-headquartered Laurus Bio Pvt Ltd by securing the remaining 8,333 equity shares from the promoter group shareholders of Laurus Bio. Laurus Labs now commands 87.59% shareholding in Laurus Bio on a fully diluted basis. Laurus Bio is an integrated research-driven biomanufacturing organisation with expertise in precision fermentation and recombinant technology. It engineers microbes as “cell-factories” to manufacture novel and sustainable animal-free proteins and growth factors that replace animal-derived products in biopharma, food, health, nutrition, and personal care markets.